MARKET

CERT

CERT

Certara, Inc.
NASDAQ
8.85
-0.04
-0.45%
After Hours: 8.85 0 0.00% 16:10 12/29 EST
OPEN
8.79
PREV CLOSE
8.89
HIGH
8.91
LOW
8.71
VOLUME
1.68M
TURNOVER
--
52 WEEK HIGH
15.69
52 WEEK LOW
8.03
MARKET CAP
1.41B
P/E (TTM)
130.92
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CERT last week (1222-1226)?
Weekly Report · 21h ago
Analysts’ Top Healthcare Picks: Certara (CERT), Gilead Sciences (GILD)
TipRanks · 12/22 18:10
Weekly Report: what happened at CERT last week (1215-1219)?
Weekly Report · 12/22 10:12
Certara (CERT) CEO Transition: Taking a Fresh Look at the Company’s Valuation After the 2026 Leadership Change
Simply Wall St · 12/19 22:43
Certara Is Maintained at Equal-Weight by Morgan Stanley
Dow Jones · 12/18 17:52
Certara Price Target Cut to $12.00/Share From $16.00 by Morgan Stanley
Dow Jones · 12/18 17:52
Morgan Stanley Maintains Equal-Weight on Certara, Lowers Price Target to $12
Benzinga · 12/18 17:42
Does Certara’s (CERT) New IQVIA-Trained CEO Mark a Strategic Shift in Its Biosimulation Focus?
Simply Wall St · 12/17 22:11
More
About CERT
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 70 countries.

Webull offers Certara Inc stock information, including NASDAQ: CERT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CERT stock methods without spending real money on the virtual paper trading platform.